Ravish Sachar, MD
Interventional Cardiology · Raleigh, NCNPI 1629076161
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.9%), ownership interests and speaking fees — rather than concentrated in one kind of arrangement. Contego Medical, Inc accounts for 88.4% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2023 at $546,885 and has fallen 98.7% since, to $7,116 in 2025. Among interventional cardiology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 740 payments — averaging $2111.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Contego Medical, Inc$1.4M
- Medtronic$117K
- Boston Scientific$49K
- Angiodynamics, Inc.$11K
- Abbott$3K
- Philips North America LLC$334
- plus $854 from 12 others
Across 190 payments — averaging $2326.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$327K
- Surmodics, Inc.$63K
- Philips North America LLC$23K
- Microvention, Inc.$16K
- Medtronic$10K
- W. L. Gore & Associates, Inc.$3K
Across 7 payments — averaging $1,168,241 each. An ownership or investment interest held by the physician or an immediate family member.
- Contego Medical, Inc$8.2M
What the payments were for
- Consulting fees$935,86360%
- Speaking & faculty fees$121,6088%
- Travel & lodging$92,0646%
- Food & beverage$23,8452%
- Ownership interest$378,03024%
- Other$11,0001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Contego Medical, Inc | 413 | $1,380,873 |
| Medtronic(2 entities) | 175 | $116,839 |
| Boston Scientific | 50 | $49,423 |
| Angiodynamics, Inc. | 3 | $11,103 |
| Abbott | 80 | $2,983 |
| Philips North America LLC | 3 | $334 |
| Cordis US CORP. | 2 | $224 |
| Abiomed | 2 | $205 |
| Cardiovascular Systems Inc. | 1 | $135 |
| Edwards Lifesciences | 2 | $84 |
| BTG International Canada Inc. | 1 | $47 |
| Mimedx Group, Inc. | 1 | $46 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $25 |
| Teleflex Medical Incorporated | 1 | $21 |
| Johnson & Johnson | 1 | $17 |
| AstraZeneca | 1 | $17 |
| Shockwave Medical, Inc | 1 | $17 |
| Amgen | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IN.PACT Admiral$39,594
- HawkOne$38,633
- TurboHawk$17,441
- Auryon Laser System 100-120 Vac$11,103
- ELUVIA$10,266
- GENERAL - THERAPIES$9,500
- Neuroguard IEP$9,269
- JETSTREAM$9,000
- GENERAL VASCULAR INTERVENTION$8,140
- FlowMet$5,700
- Pipeline$3,906
- Chocolate PTA Balloon$3,800
- JETSTREAM SC$2,117
- Ranger$2,000
- XACT$1,950
- Abre$1,404
- MO.MA ULTRA$1,090
- Vanguard$977
- Endurant$811
- Paladin Carotid PTA Balloon System with Integrated Embolic Protection, Vanguard $282
How this compares
$1,562,409 in reported general payments places this provider in the 95th percentile of 180 interventional cardiology providers in North Carolina.
See all interventional cardiology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Repatha SureclickEvolocumab | 54 | $70,258 |
| EliquisApixaban | 60 | $57,620 |
| XareltoRivaroxaban | 22 | $13,252 |
| ClopidogrelClopidogrel Bisulfate | 301 | $2,332 |
| Ranolazine ErRanolazine | 18 | $1,516 |
| Atorvastatin Calcium | 84 | $1,233 |
| Metoprolol Succinate | 72 | $802 |
| Potassium Chloride | 30 | $553 |
| Cilostazol | 28 | $361 |
| Rosuvastatin Calcium | 33 | $356 |
| Losartan Potassium | 27 | $324 |
| Isosorbide Dinitrate | 12 | $300 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 24 | $293 |
| Amlodipine Besylate | 78 | $285 |
| Lisinopril | 35 | $247 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $17 | $13,25222 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 180 interventional cardiology providers in North Carolina.
Other interventional cardiology in Raleigh
- Robert JobeRaleigh$191K
- James ZidarRaleigh$57K
- Willis WuRaleigh$56K
- Islam OthmanRaleigh$50K
- Andrew SampsonRaleigh$48K
- Dwijesh PatelRaleigh$40K
- Siva KethaRaleigh$19K
- Mohit PasiRaleigh$16K
- George AdamsGarner$4.1M
- Paul MahoneyGreenville$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.